Inhibition of Helicobacter pylori Urease Activity by Hydroxamic Acid Derivatives

65Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

Helicobacter pylori (HP) produces strong urease [EC 3.5.1.5], which is considered to play a role in the pathogenesis of gastritis and peptic ulcers. Inhibitions against this enzyme have been studied with hydroxamic acid (HXA) derivatives of aliphatic or aromatic carboxylic acids, amino acids and dipeptides. A number of HXAs potently inhibited the urease (I50 values were near the order of 10~6m), and H-Ile-Gly-NHOH (I50 = 0.20 x 10-6m) was the most potent inhibitor among the derivatives. HP urease was inhibited more potently, in general, than Jack bean (JB) urease by HXAs, and a correlation between the chemical structures of HXA derivatives and their inhibitory effects on HP urease was observed, in comparison with JB urease. © 1994, The Pharmaceutical Society of Japan. All rights reserved.

Cite

CITATION STYLE

APA

Odaki, S., Morikawa, T., Tsuchiya, M., Imamura, L., & Kobash, K. (1994). Inhibition of Helicobacter pylori Urease Activity by Hydroxamic Acid Derivatives. Biological and Pharmaceutical Bulletin, 17(10), 1329–1332. https://doi.org/10.1248/bpb.17.1329

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free